265 related articles for article (PubMed ID: 23827252)
1. Controlling inflammation: contemporary treatments for autoinflammatory diseases and syndromes.
Sterba G; Sterba Y
Dermatol Clin; 2013 Jul; 31(3):507-11. PubMed ID: 23827252
[TBL] [Abstract][Full Text] [Related]
2. Introduction to autoinflammatory syndromes and diseases.
Abramovits W; Oquendo M
Dermatol Clin; 2013 Jul; 31(3):363-85. PubMed ID: 23827242
[TBL] [Abstract][Full Text] [Related]
3. Autoinflammatory diseases in dermatology: CAPS, TRAPS, HIDS, FMF, Blau, CANDLE.
Tripathi SV; Leslie KS
Dermatol Clin; 2013 Jul; 31(3):387-404. PubMed ID: 23827243
[TBL] [Abstract][Full Text] [Related]
4. The body against self: autoinflammation and autoimmunity.
Borella E; Palma L; Zen M; Bettio S; Nalotto L; Gatto M; Domeneghetti M; Laccarino L; Punzi L; Doria A
Isr Med Assoc J; 2014 Oct; 16(10):608-10. PubMed ID: 25438443
[No Abstract] [Full Text] [Related]
5. Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome.
de Koning HD; Schalkwijk J; van der Meer JW; Simon A
J Allergy Clin Immunol; 2011 Dec; 128(6):1352-4. PubMed ID: 21704363
[No Abstract] [Full Text] [Related]
6. Autoinflammatory diseases in pediatrics.
Hausmann JS; Dedeoglu F
Dermatol Clin; 2013 Jul; 31(3):481-94. PubMed ID: 23827250
[TBL] [Abstract][Full Text] [Related]
7. Autoinflammatory conditions: when to suspect? How to treat?
Grateau G; Duruöz MT
Best Pract Res Clin Rheumatol; 2010 Jun; 24(3):401-11. PubMed ID: 20534373
[TBL] [Abstract][Full Text] [Related]
8. Therapy of autoinflammatory syndromes.
Hoffman HM
J Allergy Clin Immunol; 2009 Dec; 124(6):1129-38; quiz 1139-40. PubMed ID: 20004774
[TBL] [Abstract][Full Text] [Related]
9. What do autoinflammatory syndromes teach about common cutaneous diseases such as pyoderma gangrenosum? A commentary.
Butler D; Shinkai K
Dermatol Clin; 2013 Jul; 31(3):427-35. PubMed ID: 23827245
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.
Neven B; Marvillet I; Terrada C; Ferster A; Boddaert N; Couloignier V; Pinto G; Pagnier A; Bodemer C; Bodaghi B; Tardieu M; Prieur AM; Quartier P
Arthritis Rheum; 2010 Jan; 62(1):258-67. PubMed ID: 20039428
[TBL] [Abstract][Full Text] [Related]
11. Autoinflammatory disorders, pain, and neural regulation of inflammation.
Chen MC; Meckfessel MH
Dermatol Clin; 2013 Jul; 31(3):461-70. PubMed ID: 23827248
[TBL] [Abstract][Full Text] [Related]
12. Autoinflammatory syndromes.
Hashkes PJ; Toker O
Pediatr Clin North Am; 2012 Apr; 59(2):447-70. PubMed ID: 22560579
[TBL] [Abstract][Full Text] [Related]
13. Recurrent migratory angioedema as cutaneous manifestation in a familiar case of TRAPS: dramatic response to Anakinra.
Cattalini M; Meini A; Monari P; Gualdi G; Arisi M; Pelucchi F; Bolognini S; Gattorno M; Calzavara-Pinton PG; Plebani A
Dermatol Online J; 2013 Nov; 19(11):20405. PubMed ID: 24314780
[TBL] [Abstract][Full Text] [Related]
14. Autoinflammatory syndromes.
Cush JJ
Dermatol Clin; 2013 Jul; 31(3):471-80. PubMed ID: 23827249
[TBL] [Abstract][Full Text] [Related]
15. Anakinra as a diagnostic challenge and treatment option for systemic autoinflammatory disorders of undefined etiology.
Harrison SR; McGonagle D; Nizam S; Jarrett S; van der Hilst J; McDermott MF; Savic S
JCI Insight; 2016 May; 1(6):e86336. PubMed ID: 27699261
[TBL] [Abstract][Full Text] [Related]
16. On-demand treatment with anakinra: a treatment option for selected TRAPS patients.
Grimwood C; Despert V; Jeru I; Hentgen V
Rheumatology (Oxford); 2015 Sep; 54(9):1749-51. PubMed ID: 26078218
[No Abstract] [Full Text] [Related]
17. Sarcoid-like granulomatosis in a patient treated by interleukin-1 receptor antagonist for TNF-receptor-associated periodic syndrome.
Sacre K; Pasqualoni E; Descamps V; Choudat L; Debray MP; Papo T
Rheumatology (Oxford); 2013 Jul; 52(7):1338-40. PubMed ID: 23302761
[No Abstract] [Full Text] [Related]
18. The challenge of autoinflammatory syndromes: with an emphasis on hyper-IgD syndrome.
van der Meer JW; Simon A
Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii23-ii29. PubMed ID: 27856657
[TBL] [Abstract][Full Text] [Related]
19. Autoinflammatory syndromes for the dermatologist.
Dávila-Seijo P; Hernández-Martín A; Torrelo A
Clin Dermatol; 2014; 32(4):488-501. PubMed ID: 25017460
[TBL] [Abstract][Full Text] [Related]
20. Dermatologic Manifestations of Monogenic Autoinflammatory Diseases.
Shwin KW; Lee CR; Goldbach-Mansky R
Dermatol Clin; 2017 Jan; 35(1):21-38. PubMed ID: 27890235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
